DarioHealth Story

<div class='circular--portrait' style='background:#754DEB;color: #F0FFF0;font-size:4em;'>DC</div>
DRIO -- USA Stock  

USD 16.47  0.70  4.44%

Today's article will outline DarioHealth Corp. We will evaluate why we are still confident in anticipation of a recovery. DarioHealth Corp is currently traded for 12.40. The entity has historical hype elasticity of -0.24. The average price elasticity to hype of competition is about -8.8. The firm is forecasted to decline in value after the next headline, with the price expected to drop to 12.16. The average volatility of media hype impact on the company stock price is huge, making predictions on the news or social media along less reliable. The price decrease on the next news is expected to be -1.94%, whereas the daily expected return is currently at 1.08 percent. The volatility of related hype on DarioHealth Corp is about 97.21% with expected price after next announcement by competition of 3.6 Given the investment horizon of 30 days, the next forecasted press release will be in about 8 days.
Published over a month ago
View all stories for DarioHealth Corp | View All Stories
Volatility may be your only friend when it comes to investing in DarioHealth Corp
Our trade advice tool can cross-verify current analyst consensus on DarioHealth Corp and to analyze the company potential to grow in the current economic cycle.
The successful prediction of DarioHealth Corp stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as DarioHealth Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of DarioHealth Corp based on DarioHealth Corp hews, social hype, general headline patterns, and widely used predictive technical indicators. We also calculate exposure to DarioHealth Corp's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to DarioHealth Corp's related companies.

Use Technical Analysis to project DarioHealth expected Price

DarioHealth Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of DarioHealth Corp technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of DarioHealth Corp trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

How DarioHealth utilizes its cash?

To perform a cash flow analysis of DarioHealth Corp, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash DarioHealth Corp is receiving and how much cash it distributes out in a given period. The DarioHealth Corp cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. DarioHealth Corp Net Cash Flow from Operations is quite stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at (16.14 Million)

Acquisition by Dror Bacher of 10000 shares of DarioHealth Corp subject to Rule 16b-3

Legal trades by DarioHealth Corp insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
DarioHealth insider trading alert for grant of common stock by Dror Bacher, Chief Operating Officer, on 10th of September 2020. This event was filed by Dariohealth Corp with SEC on 2020-09-10. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

A Deeper look at DarioHealth

The company reported the previous year's revenue of 6.98 M. Net Loss for the year was (26.68 M) with profit before overhead, payroll, taxes, and interest of 2.6 M.
 2017 2018 2019 2020 (projected)
Revenues USD5.17 M7.39 M7.56 M6.27 M
Revenues5.17 M7.39 M7.56 M6.27 M

Deferred Revenue Breakdown

DarioHealth Corp Deferred Revenue yearly trend continues to be quite stable with very little volatility. Deferred Revenue may rise above about 1.3 M this year. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. DarioHealth Corp Deferred Revenue is quite stable at the moment as compared to the past year. The company's current value of Deferred Revenue is estimated at 1.32 Million
20191.22 Million
20201.32 Million

Our perspective of the latest DarioHealth Corp thrive

Risk adjusted performance is down to 0.24. It may entail a possible volatility slide. As of the 1st of August, DarioHealth Corp shows the Coefficient Of Variation of 707.98, downside deviation of 3.65, and Mean Deviation of 3.94. DarioHealth Corp technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for DarioHealth Corp, which can be compared to its rivals. Please confirm DarioHealth Corp standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if DarioHealth Corp is priced favorably, providing market reflects its regular price of 12.4 per share. Given that DarioHealth Corp has jensen alpha of 1.12, we urge you to verify DarioHealth Corp's prevailing market performance to make sure the company can sustain itself at a future point.

Our Final Take On DarioHealth Corp

Whereas some firms within the diagnostics & research industry are still a little expensive, even after the recent corrections, DarioHealth Corp may offer a potential longer-term growth to institutional investors. While some institutional investors may not share our view, we believe that right now is not a good time to increase your holdings in DarioHealth. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to DarioHealth Corp.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of DarioHealth Corp. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com